Overview
Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS) is a rare, slowly progressive neurological disorder that affects the cerebellum, peripheral nerves, and vestibular system. It is caused by biallelic intronic pentanucleotide repeat expansions (AAGGG) in the RFC1 gene. CANVAS was initially considered a sporadic condition, but it is now recognized as an autosomal recessive genetic disorder. The disease typically presents in adulthood, usually between the ages of 40 and 70, and is characterized by the triad of cerebellar ataxia (impaired coordination and balance due to cerebellar dysfunction), sensory neuropathy (damage to peripheral nerves affecting sensation), and bilateral vestibular areflexia (loss of function in both inner ear balance organs). Patients commonly experience progressive unsteadiness, oscillopsia (visual disturbance where objects appear to bounce or oscillate), impaired proprioception, and a chronic dry cough that may precede neurological symptoms by years. The combination of cerebellar, vestibular, and sensory nerve dysfunction leads to significant balance impairment that is often more severe than would be expected from any single component alone. Additional features may include autonomic dysfunction and downbeat nystagmus. Nerve conduction studies typically reveal a sensory neuronopathy (ganglionopathy), and vestibular testing confirms absent or markedly reduced vestibular responses bilaterally. Brain MRI may show cerebellar atrophy, particularly of the vermis. There is currently no disease-modifying treatment for CANVAS. Management is supportive and includes physical therapy and vestibular rehabilitation to optimize balance and mobility, occupational therapy, and assistive devices as needed. The identification of RFC1 repeat expansions as the genetic cause has significantly improved diagnostic accuracy and genetic counseling for affected families.
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
3 eventsCentre Hospitalier Universitaire de Nice — NA
Catholic University of the Sacred Heart — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome.
3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome.
Community
No community posts yet. Be the first to share your experience with Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome.
Start the conversation →Latest news about Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
Disease timeline:
New recruiting trial: Evaluation of Urinary Dysfunction in CANVAS Patients
A new clinical trial is recruiting patients for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
New recruiting trial: Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS
A new clinical trial is recruiting patients for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
New recruiting trial: RFC1 Natural History Study
A new clinical trial is recruiting patients for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
What is Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome?
Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS) is a rare, slowly progressive neurological disorder that affects the cerebellum, peripheral nerves, and vestibular system. It is caused by biallelic intronic pentanucleotide repeat expansions (AAGGG) in the RFC1 gene. CANVAS was initially considered a sporadic condition, but it is now recognized as an autosomal recessive genetic disorder. The disease typically presents in adulthood, usually between the ages of 40 and 70, and is characterized by the triad of cerebellar ataxia (impaired coordination and balanc
How is Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome inherited?
Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome typically begin?
Typical onset of Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome is adult. Age of onset can vary across affected individuals.
Are there clinical trials for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome?
Yes — 3 recruiting clinical trials are currently listed for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome?
3 specialists and care centers treating Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.